Browse > Article

Suppressive Effects of Furonaphthoquinone NFD-37 on the Production of Lipopolysaccharide-Inducible Inflammatory Mediators in Macrophages RAW 264.7  

Kim Min-Hee (College of Pharmacy & Research Center for Bioresource and Health, Chungbuk National University)
Shin Hyun-Mo (College of Pharmacy & Research Center for Bioresource and Health, Chungbuk National University)
Lee Yong Rok (School of Chemical Engineering and Technology, Yeungnam University)
Chung Eun Yong (College of Pharmacy & Research Center for Bioresource and Health, Chungbuk National University)
Chang Yoon Sook (College of Pharmacy & Research Center for Bioresource and Health, Chungbuk National University)
Min Kyung Rak (College of Pharmacy & Research Center for Bioresource and Health, Chungbuk National University)
Kim Youngsoo (College of Pharmacy & Research Center for Bioresource and Health, Chungbuk National University)
Publication Information
Archives of Pharmacal Research / v.28, no.10, 2005 , pp. 1170-1176 More about this Journal
Abstract
2-Methyl-2-(2-methylpropenyl)-2,3-dihydronaphthoquinone[2,3-b]furan-4,9-dione (N FD-37) is a synthetic furonaphthoquinone compound. In this study, we determined that NFD-37 could inhibit the lipopolysaccharide (LPS)-induced production of inflammatory mediators in macrophages RAW 264.7. This compound inhibited LPS-induced nitric oxide (NO) or prostaglandin (PG) $E_{2}$ production in dose-dependent manners, with $IC_{50}$ values of 7.2 ${\mu}M$ and 5.3 ${\mu}m$, respectively. As the positive controls, pyrrolidine dithiocarbamate (30 ${\mu}M$) exhibited a $57{\%}$ inhibition of NO production, and NS-398 ($1{\mu}M$) manifested a $48{\%}$ inhibition of $PGE_2$ production. The inhibitory effects of NFD-37 on NO and $PGE_2$ production were determined to occur in conjunction with the suppression of inducible NO synthase or cyclooxygenase-2 expression. NFD-37 also inhibited the production of LPS-inducible tumor necrosis factor-${\alpha}$, interleukin (IL)-$1{\beta}$ and IL-6, at $IC_{50}$ values of 4.8-8.9 ${\mu}M$. We also determined the anti-inflammatory efficacy of NFD-37 using carrageenin-induced paw edema in experimental mice.
Keywords
Furonaphthoquinone; NO; Cytokine; Anti-inflammation;
Citations & Related Records

Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 2
연도 인용수 순위
1 Arakawa, T., Higuchi, K., Fukuda, T., Fujiwara, Y., Kobayashi, K., and Kuroki, T., Prostaglandins in the stomach: an update. J. Clin. Gastroenterol., 27, S1-S11 (1998)   DOI   ScienceOn
2 Ignarro, L. J., Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J. Physiol. Pharmacol., 53, 503-514 (2002)
3 Jones, K. J., Perris, A. D., Vernallis, A. B., Worthington, T., Lambert, P. A., and Elliott, T. S., Induction of inflammatory cytokines and nitric oxide in J774.2 cells and murine macrophages by lipoteichoic acid and related cell wall antigens from Staphylococcus epidermidis. J. Med. Microbiol., 54, 315-321 (2005)   DOI   ScienceOn
4 Tian, B. and Brasier, A. R., Identification of a nuclear factor ${\kappa}B$-dependent gene network. Recent Prog. Harm. Res., 58, 95-130 (2003)   DOI   ScienceOn
5 MacMicking, J., Xie, Q. W., and Nathan, C., Nitric oxide and macrophage function. Annu. Rev. Immunol., 15, 323-350 (1997)   DOI   ScienceOn
6 Shin, H.-M., Kim, M.-H., Kim, B. H., Jung, S.-H., Kim, Yl S., Park, H. J., Hong, J. T., Min, K. R., and Kim, Yl, Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of $NF-\kappa B$ without affecting $l\kappa B$ degradation. FEBS Lett., 571, 50-54 (2004)   DOI   PUBMED   ScienceOn
7 Becker, J. C., Domschke, W., and Pohle, T., Current approaches to prevent NSAID-induced gastropathy: COX selectivity and beyond. Br. J. Clin. Pharmacol., 58, 587-600 (2004)   DOI   ScienceOn
8 Sanceau, J., Kaisho, T., Hirano, T., and Wietzerbin, J., Triggering of the human interleukin-6 gene by interferon-$\gamma$ and tumor necrosis $factor-\alpha$ in monocytic cells involves cooperation between interferon regulatory factor-1, $NF-{\kappa}B$, and Sp1 transcription factors. J. Biol. Chem., 270, 27920-27931 (1995)   DOI   ScienceOn
9 Lee, Y.R., Suk, J. Y., and Kim, B. S., One-pot construction of medium- and large-sized ring substituted furans: efficient conversion to dibenzofurans, coumestans, and 4-pyrones. Org. Lett., 2, 1387-1389 (2000)   DOI   ScienceOn
10 Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A.M., Snyder, S. H., Russell, S. W, and Murphy, W. J., Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A., 15, 9730-9734 (1993)   DOI
11 Crofford, L. J., Wilder, R. L., Ristimaki, A. P., Sano, H., Remmers, E. F., Epps, H. R., and Hla, T., Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-$1\beta$, phorbol ester, and corticosteroids. J. Clin. Invest., 93, 1095-1101 (1994)   DOI   ScienceOn
12 Prast, H. and Philippu, A., Nitric oxide as modulator of neuronal function. Prog. Neurobiol., 64, 51-68 (2001)   DOI   ScienceOn
13 Bovill, J. G., Pharmacology and clinical action of COX-2 selective NSAIDs. Adv. Exp. Med. Biol., 523, 201-214 (2003)
14 Hopkins, S. J., The pathophysiological role of cytokines. Leg. Med., 5, S45-S57 (2003)   DOI   ScienceOn
15 Kamimura, D., Ishihara, K., and Hirano, T., IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol., 149, 1-38 (2003)   DOI
16 Watkins, L. R., Nguyen, K. T., Lee, J. E., and Maier, S. F., Dynamic regulation of pro-inflammatory cytokines. Adv. Exp. Med. Biol., 461, 153-178 (1999)   DOI
17 Masferrer, J. L., Zweifel, B. S., Colburn, S. M., Ornberg, R. L., Salvemini, D., Isakson, P. and Seibert, K., The role of cyclooxygenase-2 in inflammation. Am. J. Ther., 2, 607-610 (1995)   DOI   ScienceOn
18 Koss, K., Satsangi, J., Welsh, K. I., and Jewell, D. P., Is interleukin-6 important in inflammatory bowel disease? Genes lmmun., 1, 207-212 (2000)   DOI   ScienceOn
19 Brater, D. C., Anti-inflammatory agents and renal function. Semin. Arthritis Rheum., 32, 33-42 (2002)   DOI   PUBMED   ScienceOn
20 Guha, M. and Mackman, N., LPS induction of gene expression in human monocytes. Cell Signal., 13, 85-94 (2001)   DOI   ScienceOn
21 Inoue, H. and Tanabe, T., Transcriptional regulation of human prostaglandin endoperoxide synthase-2 gene in vascular endothelial cells. Adv. Exp. Med. Biol., 407, 139-144 (1997)
22 Wong, P. K., Campbell, I. K., Egan, P. J., Ernst, M., and Wicks, I. P., The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. Arthritis Rheum., 48, 1177-1189 (2003)   DOI   ScienceOn
23 van den Berg, W. B., Joosten, L. A., and van de Loo, F. A., $TNF\alpha$ and IL-$1\beta$ are separate targets in chronic arthritis. Clin. Exp. Rheumatol., 17, S105-S114 (1999)